Thursday, April 11, 2019 / Categories: DOPPS, CKDopps, Plain Language Summary, Visual Abstract The Experience of Pruritus in CKD How distress from itchy skin impacts patient health and quality of life Recent findings from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) advance our knowledge of the patient experience of pruritus, or itchy skin, early in the lifecycle of kidney disease. Nidhi Sukul, MD The study, which appears in the April 2019 issue of the Clinical Journal of the American Society of Nephrology (CJASN), is the work of an Arbor Research Collaborative for Health/CKDopps team led by Nidhi Sukul, MD (University of Michigan). This study is the first of its kind to evaluate the prevalence of pruritus and its association with patient-reported outcomes in such a large, international sample of patients with non-dialysis chronic kidney disease (CKD). The major findings of this work include: A 24% prevalence of moderate-to-extreme pruritus among patients with non-dialysis CKD in Brazil, France, and the United States (US), ranging from nearly 23% in Brazil to 29% in the US, with higher prevalence in later stages of CKD. Patient characteristics associated with more severe pruritus included patient age ≥70, female sex, and advanced kidney disease. Comorbid lung disease, diabetes, and physician-diagnosed depression were also associated with moderate-to-extreme pruritus. More severe itching was linked to increasingly poor mental and physical health, self-reported depressive symptoms, and self-reported restless sleep. Patients with extreme pruritus had more than twice the prevalence of self-reported restless sleep when compared with those without. Some findings are similar to those among patients receiving hemodialysis. The association of diabetes with pruritus among patients with kidney disease may be related to the peripheral neuropathy linking both disorders. We don’t yet fully understand how uremic pruritus develops and progresses, but it is possible that inflammation or low hemoglobin levels may play roles. It is conceivable that the higher prevalence of depression seen in patients with more severe pruritus could be related to the restless sleep and fatigue that worsen with pruritus, as disturbed sleep has a known relationship with impaired quality of life, depression, and mortality. These findings underscore the importance of identifying CKD patients who suffer from pruritus in order to potentially provide relief and improve quality of life. This study lays the groundwork for future and prospective studies of pruritus severity across the course of kidney disease. “One of the main goals of managing chronic disease is alleviating symptoms; however, this is only possible when we are aware of the suffering patients endure,” said Dr. Sukul. “This research gives us a uniquely international look at how important it is to ask our patients with chronic kidney disease if and how they are affected by pruritus. Some drugs have been shown to largely improve pruritus-related symptoms for a substantial percentage of patients, but even if we do not have a universally effective treatment for pruritus, recognizing that pruritus ails our patients and affects their quality of life will make them feel heard and enhance the patient-physician relationship in discussing approaches that may help provide relief from pruritus.” CITATION:Sukul N, Speyer E, Tu C, Bieber BA, Li Y, Lopes AA, Asahi K, Mariani L, Laville M, Rayner HC, Stengel B, Robinson BM, Pisoni RL, on behalf of CKDopps and CKD-REIN investigators. Pruritus and Patient Reported Outcomes in Non-Dialysis CKD. CJASN Apr 2019, CJN.09600818; DOI: 10.2215/CJN.09600818 Previous Article Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States Next Article 2020 ASTS Vanguard Award Print More links The study at Clinical Journal of American Society of NephrologyManuscript publication April 2019 Download the free full text PDF Featured in Renal and Urology News
DOPPS Program Spring Scientific Update Meeting via webinar on Friday, June 9th from 8am – 11am Wednesday, May 31, 2023
Arbor Research Collaborative for Health Welcomes New Vice President (VP) of Research, Dr. Cori Sheedy Thursday, April 6, 2023
Arbor Research Collaborative for Health Welcomes Research Scientist, Dr. Christine Stanik Wednesday, February 15, 2023
Arbor Research Awarded a $1.5M Contract to Support AHRQ in Developing their Patient-Centered Outcomes Research Trust Fund (PCORTF) Strategic Plan Thursday, December 8, 2022
Arbor Research Collaborative for Health Awarded $1.2 Million Contract from CDC to Help Nursing Homes Use Electronic Health Records to Report Healthcare Acquired Infections Thursday, October 20, 2022
Arbor Research Collaborative for Health to Serve on Team Evaluating the End-Stage Renal Disease Treatment Choices Model and the Kidney Care Choices Model Friday, September 16, 2022
Arbor Research Collaborative for Health Announces Partnership with Altarum to Support and Evaluate the National Hypertension Control Initiative Tuesday, April 26, 2022
Arbor Research Collaborative for Health Announces Hire of Chauncey Lynch, BS, as Vice President of Finance & Chief Financial Officer Monday, March 28, 2022
PDOPPS: International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival Friday, March 18, 2022
Arbor Research Collaborative for Health Announces Hire of Shanthy Edward, M.A., Psy.D. as Vice President of Strategic Growth & Chief Growth Officer Monday, March 7, 2022